Medicine
Allopurinol 300 mg tablet
Allopurinol 300 mg tablet is a generic prescription medicine for oral use, made by 41 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), in a dry place.
Key facts
- Active ingredient (INN)
- Allopurinol
- Brand
- Sold under the generic name
- Strength
- 300 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 1000 tablets, 100 tablets, 500 tablets and 191 more
- Manufacturers
- Zydus LifesciencesIndiaCamber PharmaceuticalsIndiaSun Pharmaceutical IndustriesIndiaIndoco RemediesIndiaUnichem LaboratoriesIndiaAccord HealthcareIndiaAurobindo PharmaIndiaDr. Reddy's LaboratoriesIndiaAvet PharmaceuticalsIndiaFlorida Pharmaceutical Products41 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), in a dry place.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- M04AA01 Allopurinol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 24 October 1986
- Identifiers
- RxCUI 197320, 197319, 245422DailyMed set ID d9961781-cfe8-459b-920d-eb000d45d41f, 278df77c-3a9c-4c7d-ba8f-eb33f6335ef4, fbac3b4f-dc23-4359-ac3f-2b3fdde41af2 +37NDC 71335-3082, 71610-064, 0603-2116 +37Application ANDA217748, ANDA071587, ANDA075798 +11
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 41 labelers. The register lists 194 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1000 tablet in 1 bottle | 70710-1210-0 | Zydus LifesciencesIndia | 8 February 2018 |
| 100 tablet in 1 bottle | 70710-1210-1 | Zydus LifesciencesIndia | 8 February 2018 |
| 500 tablet in 1 bottle | 70710-1210-5 | Zydus LifesciencesIndia | 8 February 2018 |
| 1000 tablet in 1 bottle | 70771-1127-0 | Zydus LifesciencesIndia | 8 February 2018 |
| 100 tablet in 1 bottle | 70771-1127-1 | Zydus LifesciencesIndia | 8 February 2018 |
| 500 tablet in 1 bottle | 70771-1127-5 | Zydus LifesciencesIndia | 8 February 2018 |
| 100 tablet in 1 bottle | 16729-135-01 | Accord HealthcareIndia | 29 April 2015 |
| 500 tablet in 1 bottle | 16729-135-16 | Accord HealthcareIndia | 29 April 2015 |
| 100 tablet in 1 bottle | 59651-286-01 | Aurobindo PharmaIndia | 14 April 2025 |
| 500 tablet in 1 bottle | 59651-286-05 | Aurobindo PharmaIndia | 14 April 2025 |
| 500 tablet in 1 bottle | 23155-694-05 | Avet PharmaceuticalsIndia | 22 September 2020 |
| 100 tablet in 1 bottle | 31722-253-01 | Camber PharmaceuticalsIndia | 3 August 2023 |
| 500 tablet in 1 bottle | 31722-253-05 | Camber PharmaceuticalsIndia | 3 August 2023 |
| 1000 tablet in 1 bottle | 31722-253-10 | Camber PharmaceuticalsIndia | 3 August 2023 |
| 90 tablet in 1 bottle | 31722-253-90 | Camber PharmaceuticalsIndia | 3 August 2023 |
| 100 tablet in 1 bottle | 55111-730-01 | Dr. Reddy's LaboratoriesIndia | 1 October 2009 |
| 500 tablet in 1 bottle | 55111-730-05 | Dr. Reddy's LaboratoriesIndia | 1 October 2009 |
| 1000 tablet in 1 bottle | 14445-171-00 | Indoco RemediesIndia | 28 July 2016 |
| 100 tablet in 1 bottle | 14445-171-01 | Indoco RemediesIndia | 28 July 2016 |
| 500 tablet in 1 bottle | 14445-171-05 | Indoco RemediesIndia | 28 July 2016 |
| 100 tablet in 1 bottle, plastic | 53489-157-01 | Sun Pharmaceutical IndustriesIndia | 9 January 1987 |
| 50 tablet in 1 bottle, plastic | 53489-157-02 | Sun Pharmaceutical IndustriesIndia | 9 January 1987 |
| 30 tablet in 1 bottle, plastic | 53489-157-07 | Sun Pharmaceutical IndustriesIndia | 9 January 1987 |
| 1000 tablet in 1 bottle, plastic | 53489-157-10 | Sun Pharmaceutical IndustriesIndia | 9 January 1987 |
| 100 tablet in 1 bottle, plastic | 29300-350-01 | Unichem LaboratoriesIndia | 12 March 2019 |
| 500 tablet in 1 bottle, plastic | 29300-350-05 | Unichem LaboratoriesIndia | 12 March 2019 |
| 1000 tablet in 1 bottle, plastic | 29300-350-10 | Unichem LaboratoriesIndia | 12 March 2019 |
| 500 tablet in 1 bottle, plastic | 0591-5544-05 | Actavis Pharma | 6 April 2009 |
| 300 tablet in 1 bottle | 62135-517-31 | Chartwell RX | 27 January 2023 |
| 90 tablet in 1 bottle | 62135-517-90 | Chartwell RX | 27 January 2023 |
| 100 tablet in 1 bottle | 71921-242-01 | Florida Pharmaceutical Products | 31 October 2023 |
| 500 tablet in 1 bottle | 71921-242-50 | Florida Pharmaceutical Products | 31 October 2023 |
| 1000 tablet in 1 bottle | 71921-242-60 | Florida Pharmaceutical Products | 31 October 2023 |
| 100 tablet in 1 bottle | 82638-113-02 | Harman Finochem | 6 October 2023 |
| 500 tablet in 1 bottle | 82638-113-03 | Harman Finochem | 6 October 2023 |
| 1000 tablet in 1 bottle | 82638-113-04 | Harman Finochem | 6 October 2023 |
| 100 tablet in 1 bottle | 69315-292-01 | Leading Pharma | 1 May 2024 |
| 500 tablet in 1 bottle | 69315-292-05 | Leading Pharma | 1 May 2024 |
| 1000 tablet in 1 bottle | 69315-292-10 | Leading Pharma | 1 May 2024 |
| 100 blister pack in 1 carton / 1 tablet in 1 blister pack | 51079-206-20 | Mylan Institutional | 29 April 1997 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 19 August 1966 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Allopurinol
Clinical summary
Allopurinol is a xanthine oxidase inhibitor indicated for the management of adults with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy) The management of adult. MedsAcross supplies Allopurinol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AllopurinolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Allopurinol prescribing information (Rising Pharma Holdings) · U.S. National Library of Medicine, DailyMed
Need Allopurinol 300 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.